Latest News about CLSD
Recent news which mentions CLSD
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 11, 2022
From Benzinga
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
March 11, 2022
From Benzinga
From Benzinga
From InvestorPlace
30 Stocks Moving in Friday's Pre-Market Session
March 11, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 25, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 24, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
December 31, 2021
From InvestorPlace
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
Clearside Biomedical's Return On Capital Employed Insights
November 10, 2021
Tickers
CLSD
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
7 Top-Rated Pharmaceutical Stocks To Invest in for October
October 04, 2021
From InvestorPlace
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
How Good Are Clearside Biomedical's Earnings? | Return On Capital Employed
September 21, 2021
Tickers
CLSD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.